| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Pierluigi Paracchi | 9.8% | -22% | $3,430,519 | +$4,897 | 2,302,516 | +0.14% | Pierluigi Paracchi | 25 Jan 2026 |
As of 31 Dec 2025, 15 institutional investors reported holding 2,713,936 shares of Genenta Science S.p.A. - Ordinary Shares (GNTA). This represents 12% of the company’s total 23,495,061 outstanding shares.
The largest institutional shareholders of Genenta Science S.p.A. - Ordinary Shares (GNTA) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 2.8% | 655,164 | +5147% | 0% | $976,194 |
| Eurizon Capital SGR S.p.A. | 1.5% | 360,000 | 0% | 0% | $536,400 |
| Ghisallo Capital Management LLC | 1.4% | 323,797 | 0.02% | $482,458 | |
| Weiss Asset Management LP | 1.4% | 322,026 | 0.01% | $479,819 | |
| Allianz SE | 1% | 234,050 | 0% | 0% | $348,735 |
| NORGES BANK | 0.96% | 226,178 | 0% | $337,005 | |
| Alyeska Investment Group, L.P. | 0.94% | 219,838 | 0% | $327,559 | |
| AlTi Global, Inc. | 0.85% | 200,288 | 0% | 0.01% | $298,429 |
| ALGEBRIS (UK) LTD | 0.43% | 100,000 | 0% | 0.01% | $149,070 |
| MORGAN STANLEY | 0.2% | 45,900 | +1986% | 0% | $68,391 |
| SmartHarvest Portfolios, LLC | 0.08% | 17,781 | 0% | 0.01% | $26,494 |
| UBS Group AG | 0.01% | 3,416 | 0% | $5,090 | |
| GAMMA Investing LLC | 0.01% | 2,827 | 0% | $4,212 | |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | 2,668 | -11% | 0% | $3,815 |
| Farther Finance Advisors, LLC | 0% | 3 | 0% | $4 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,713,936 | $4,043,675 | +$2,658,375 | $1.49 | 15 |
| 2025 Q3 | 552,024 | $1,766,434 | +$48,140 | $3.18 | 6 |
| 2025 Q2 | 537,320 | $1,822,411 | -$112 | $3.04 | 5 |
| 2025 Q1 | 537,329 | $2,104,646 | +$687,343 | $3.97 | 5 |
| 2024 Q4 | 359,705 | $1,424,313 | +$36,369 | $4.09 | 4 |
| 2024 Q3 | 350,900 | $1,475,973 | +$47,052 | $4.27 | 5 |
| 2024 Q2 | 339,881 | $1,044,754 | -$820,381 | $3.10 | 5 |
| 2024 Q1 | 524,054 | $1,917,986 | -$7,938 | $3.50 | 5 |
| 2023 Q4 | 433,114 | $1,789,821 | -$100,997 | $4.54 | 4 |
| 2023 Q3 | 458,047 | $2,291,022 | -$4,126 | $5.01 | 3 |
| 2023 Q2 | 458,747 | $2,733,216 | +$2,463,126 | $5.92 | 4 |
| 2023 Q1 | 45,500 | $273,797 | -$19,569 | $5.91 | 2 |
| 2022 Q4 | 49,058 | $264,434 | +$245,030 | $5.50 | 4 |
| 2022 Q3 | 3,528 | $17,000 | -$2,009 | $4.48 | 2 |
| 2022 Q2 | 3,709 | $27,000 | -$305,119 | $7.87 | 3 |
| 2022 Q1 | 47,374 | $332,000 | +$1,574 | $7.13 | 3 |
| 2021 Q4 | 47,163 | $517,000 | +$517,000 | $11.03 | 2 |